These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1239 related items for PubMed ID: 27635163

  • 1. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.
    Tana C, Tana M, Rossi S, Silingardi M, Schiavone C.
    J Ultrasound; 2016 Sep; 19(3):183-9. PubMed ID: 27635163
    [Abstract] [Full Text] [Related]

  • 2. Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspective.
    Tana C, Schiavone C, Ticinesi A, Lauretani F, Nouvenne A, Dietrich CF, Meschi T.
    Int J Immunopathol Pharmacol; 2018 Sep; 32():2058738418781373. PubMed ID: 29873275
    [Abstract] [Full Text] [Related]

  • 3. Effect of severity of steatosis as assessed ultrasonographically on hepatic vascular indices in non-alcoholic fatty liver disease.
    Mohammadi A, Ghasemi-rad M, Zahedi H, Toldi G, Alinia T.
    Med Ultrason; 2011 Sep; 13(3):200-6. PubMed ID: 21894290
    [Abstract] [Full Text] [Related]

  • 4. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease.
    Nasr P, Hilliges A, Thorelius L, Kechagias S, Ekstedt M.
    Scand J Gastroenterol; 2016 Sep; 51(9):1126-32. PubMed ID: 27161854
    [Abstract] [Full Text] [Related]

  • 5. Liver hemodynamic patterns in nonalcoholic steatosis: Doppler ultrasonography and histological evaluation.
    Gonçalves Dos Reis Monteiro ML, Ferreira De Almeida E Borges V, Machado De Alcântara T, Borges De Araújo L, De Fátima Pinheiro C, Lemos Debs Diniz A.
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):19-29. PubMed ID: 26887796
    [Abstract] [Full Text] [Related]

  • 6. Assessment of Portal Venous and Hepatic Artery Haemodynamic Variation in Non-Alcoholic Fatty Liver Disease (NAFLD) Patients.
    Balasubramanian P, Boopathy V, Govindasamy E, Venkatesh BP.
    J Clin Diagn Res; 2016 Aug; 10(8):TC07-10. PubMed ID: 27656524
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
    García-Monzón C, Vargas-Castrillón J, Porrero JL, Alonso MT, Bonachía O, Castillo MJ, Marcos A, Quirós E, Ramos B, Sánchez-Cabezudo C, Villar S, Sáez A, Rodríguez de Cía J, del Pozo E, Vega-Piris L, Soto-Fernández S, Lo Iacono O, Miquilena-Colina ME.
    Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
    [Abstract] [Full Text] [Related]

  • 10. Doppler ultrasound of hepatic and system hemodynamics in patients with alcoholic liver cirrhosis.
    Zekanovic D, Ljubicic N, Boban M, Nikolic M, Delic-Brkljacic D, Gacina P, Klarin I, Turcinov J.
    Dig Dis Sci; 2010 Feb; 55(2):458-66. PubMed ID: 19277866
    [Abstract] [Full Text] [Related]

  • 11. Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Daher S, Lev Cohen N, Massarwa M, Mahamid M, Nasser M, Hazou W, Oren R, Safadi R, Khoury T.
    PLoS One; 2018 Feb; 13(11):e0207479. PubMed ID: 30500848
    [Abstract] [Full Text] [Related]

  • 12. Shear Wave Elastography for Assessment of Steatohepatitis and Hepatic Fibrosis in Rat Models of Non-Alcoholic Fatty Liver Disease.
    Kang BK, Lee SS, Cheong H, Hong SM, Jang K, Lee MG.
    Ultrasound Med Biol; 2015 Dec; 41(12):3205-15. PubMed ID: 26349582
    [Abstract] [Full Text] [Related]

  • 13. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.
    Karlas T, Berger J, Garnov N, Lindner F, Busse H, Linder N, Schaudinn A, Relke B, Chakaroun R, Tröltzsch M, Wiegand J, Keim V.
    World J Gastroenterol; 2015 Apr 28; 21(16):4894-902. PubMed ID: 25945002
    [Abstract] [Full Text] [Related]

  • 14. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
    McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM.
    J Hepatol; 2015 May 28; 62(5):1148-55. PubMed ID: 25477264
    [Abstract] [Full Text] [Related]

  • 15. Nonalcoholic fatty liver disease: portal hypertension due to outflow block in patients without cirrhosis.
    Hirooka M, Koizumi Y, Miyake T, Ochi H, Tokumoto Y, Tada F, Matsuura B, Abe M, Hiasa Y.
    Radiology; 2015 Feb 28; 274(2):597-604. PubMed ID: 25302830
    [Abstract] [Full Text] [Related]

  • 16. Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
    Khov N, Sharma A, Riley TR.
    World J Gastroenterol; 2014 Jun 14; 20(22):6821-5. PubMed ID: 24944472
    [Abstract] [Full Text] [Related]

  • 17. Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Tovo CV, Villela-Nogueira CA, Leite NC, Panke CL, Port GZ, Fernandes S, Buss C, Coral GP, Cardoso AC, Cravo CM, Calçado FL, Rezende GFM, Ferreira FC, Araujo-Neto JM, Perez RM, Moraes-Coelho HS, de Mattos AA.
    Ann Hepatol; 2019 Jun 14; 18(3):445-449. PubMed ID: 31031166
    [Abstract] [Full Text] [Related]

  • 18. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH, Kim KJ, Yoo ME, Kim G, Yoon HJ, Jo K, Youn JC, Yun M, Park JY, Shim CY, Lee BW, Kang SM, Ha JW, Cha BS, Kang ES.
    J Hepatol; 2018 Apr 14; 68(4):764-772. PubMed ID: 29175242
    [Abstract] [Full Text] [Related]

  • 19. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).
    Tasneem AA, Luck NH, Majid Z.
    Trop Doct; 2018 Apr 14; 48(2):107-112. PubMed ID: 29145775
    [Abstract] [Full Text] [Related]

  • 20. Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease.
    Takeuchi H, Sugimoto K, Oshiro H, Iwatsuka K, Kono S, Yoshimasu Y, Kasai Y, Furuichi Y, Sakamaki K, Itoi T.
    J Med Ultrason (2001); 2018 Apr 14; 45(2):243-249. PubMed ID: 29128938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.